耳蜗电图模式预测人工耳蜗植入后阻抗升高与听力损失
研究前瞻性纳入39例有残余低频听力并植入细直电极阵列的受试者,分析耳蜗电图模式与四点阻抗及残余听力保存的关系。结果显示,中峰及尖峰至中峰模式者术后阻抗更高、听力损失更大,提示这些模式与耳蜗内纤维化增加相关。
要点
- 耳蜗电图尖峰模式者术后3个月听力损失平均13 dB,中峰模式28 dB,尖峰至中峰模式35 dB。
- 尖峰模式组四点阻抗均值222 Ω,低于中峰组295 Ω和尖峰至中峰组234 Ω。
- 中峰及尖峰至中峰模式与更高阻抗和更差术后听力相关,提示耳蜗内纤维化增加。
核心结论
- 中峰和尖峰至中峰耳蜗电图反应模式与更高四点阻抗及更差术后听力相关,提示这些模式与耳蜗内纤维化增加有关。
研究设计与样本
- 前瞻性纳入39例有残余低频听力并植入细直电极阵列的受试者,于完全插入后即刻和术后3个月行耳蜗内耳蜗电图记录及沿22个电极的四点阻抗测量,术后3个月评估听力保存。
主要发现
- 围手术期耳蜗电图记录中,22例(56%)最大振幅位于电极阵列尖端附近(尖峰模式,EL20或EL22),17例(44%)最大振幅位于更基底区域(中峰模式,EL18或更低)。
- 术后3个月,6例围手术期尖峰模式者最大耳蜗电图反应位置向基底移位(尖峰至中峰模式)。
- 在可辨别潜伏期的68份围手术期和术后记录(占全部78份记录的87%)中,尖峰模式记录(n=38)潜伏期随插入深度增加而延长,最大潜伏期移位的电极中位数为EL21;中峰模式记录(n=30)最大潜伏期移位更靠基底,电极中位数为EL12,p < 0.001。
- 围手术期尖峰模式记录的振幅与术前听阈相关(r²=0.351,p=0.004),中峰模式记录中未检测到这种相关性(r²=0.033,p=0.484)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Different patterns of electrocochleographic responses along the electrode array after insertion of the cochlear implant electrode array have been described. However, the implications of these patterns remain unclear. Therefore, the aim of the study was to correlate different peri- and postoperative electrocochleographic patterns with four-point impedance measurements and preservation of residual hearing. DESIGN: Thirty-nine subjects with residual low-frequency hearing which were implanted with a slim-straight electrode array could prospectively be included. Intracochlear electrocochleographic recordings and four-point impedance measurements along the 22 electrodes of the array (EL, most apical EL22) were conducted immediately after complete insertion and 3 months after surgery. Hearing preservation was assessed after 3 months. RESULTS: In perioperative electrocochleographic recordings, 22 subjects (56%) showed the largest amplitude around the tip of the electrode array (apical-peak, AP, EL20 or EL22), whereas 17 subjects (44%) exhibited a maximum amplitude in more basal regions (mid-peak, MP, EL18 or lower). At 3 months, in six subjects with an AP pattern perioperatively, the location of the largest electrocochleographic response had shifted basally (apical-to-mid-peak, AP-MP). Latency was analyzed along the electrode array when this could be discerned. This was the case in 68 peri- and postoperative recordings (87% of all recordings, n = 78). The latency increased with increasing insertion depth in AP recordings (n = 38, median of EL with maximum latency shift = EL21). In MP recordings (n = 30), the maximum latency shift was detectable more basally (median EL12, p < 0.001). Four-point impedance measurements were available at both time points in 90% (n = 35) of all subjects. At the 3-month time point, recordings revealed lower impedances in the AP group (n = 15, mean = 222 Ω, SD = 63) than in the MP (n = 14, mean = 295 Ω, SD= 7 6) and AP-MP groups (n = 6, mean = 234 Ω, SD = 129; AP versus MP p = 0.026, AP versus AP-MP p = 0.023, MP versus AP-MP p > 0.999). The amplitudes of perioperative AP recordings showed a correlation with preoperative hearing thresholds ( r2 =0.351, p = 0.004). No such correlation was detectable in MP recordings ( r2 = 0.033, p = 0.484). Audiograms were available at both time points in 97% (n = 38) of all subjects. The mean postoperative hearing loss in the AP group was 13 dB (n = 16, SD = 9). A significantly larger hearing loss was detectable in the MP and AP-MP groups with 28 (n = 17, SD = 10) and 35 dB (n = 6, SD = 13), respectively (AP versus MP p = 0.002, AP versus AP-MP p = 0.002, MP versus AP-MP p = 0.926). CONCLUSION: MP and AP-MP response patterns of the electrocochleographic responses along the electrode array after cochlear implantation are correlated with higher four-point impedances and poorer postoperative hearing compared to AP response patterns. The higher impedances suggest that MP and AP-MP patterns are associated with increased intracochlear fibrosis.
引用
- Bester C, Dalbert A, Collins A, et al. Electrocochleographic Patterns Predicting Increased Impedances and Hearing Loss after Cochlear Implantation. Ear Hear. 2022. PMID: 36550618. doi:10.1097/AUD.0000000000001319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。